OTLK — Outlook Therapeutics Share News
0.000.00%
Last trade - 00:00- $126.42m
- $133.41m
- $1.41m
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies
Outlook Therapeutics drops on $55 mln stock-and-warrants offering
Brief: Outlook Therapeutics - Terminates May 13, 2026 Prospectus Supplement For ATM Offering Agreement With H.C. Wainwright
Brief: Outlook Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
Outlook Therapeutics falls after starting equity offering
Outlook Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Outlook Therapeutics rises after US FDA approves eye disease drug
NASDAQ RESUMED AT 03:05 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:00 PM
NASDAQ RESUMED AT 03:00 PM
US FDA approves Outlook Therapeutics' eye disease drug (updated)
Brief: Outlook Therapeutics Announces LYTENAVA FDA Approval For Treatment Of Wet AMD
US FDA approves Outlook Therapeutics' eye disease drug
NASDAQ TRADE HALT HALT NEWS PENDING AT 01:34 PM